New shoulder implant MIRAI put to the test in 76 patients
NCT ID NCT05128500
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study followed 76 adults who received a total shoulder replacement using the MIRAI modular prosthesis. Researchers measured how well the shoulder functioned and how stable the implant was over five years. The goal was to see if the implant helps patients move better and lasts without major problems.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- MIRAI Modular Shoulder Prosthesis System (a shoulder replacement implant)
- What this could lead to
- If successful, this could confirm that the MIRAI shoulder implant is a safe and effective option for people needing shoulder replacement, helping them regain movement and reduce pain.
- What could go wrong
- This is an observational study, not a controlled trial, so results may not prove the implant is better than others. Also, 5 years is medium-term; longer follow-up is needed to know how long the implant truly lasts.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
76 people
The number who actually took part.
- Started
-
Jul 2019
- Finished
-
Jan 2025
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients who are about to undergo a primary total shoulder arthroplasty in daily clinical practice, referring to one of the project investigator at the study site will be proposed to partecipate to the study.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * both genders * at least 18 years old of age * undergoing a primary total shoulder arthroplasty with MIRAI® Prosthesis System (anatomic or reverse, stemless or stemmed). * Signed informed consent Exclusion Criteria: * Patients requiring a revision shoulder arthroplasty * Persistent chronic or acute infections and all septic conditions * Persistent osteomyelitis local or systemic * Allergy or hypersensitivity to the substances contained in the materials of the implanted components * Acute or chronic neurological and/or musculoskeletal impairment which compromises the shoulder joint function such as an axillary nerve injury affecting the deltoid muscle * Inadequate bone structure which cannot guarantee stability to the prosthetic components * Several vascular, nerve or muscular disorders, which compromise related extremities * Marked osteoporosis, osteomalacia * Hypotrophy of the periarticular soft tissues * Dysmetabolic diseases such as, for example, kidney failure or systemic diseases * Muscular insufficiency * Active neoplastic or metastatic diseases * Any other clinical or physical condition that can invalidate the surgery, the rehabilitation or the prosthesis stability * Patient unwilling or unable to undergo the rehabilitation or to return to follow-up visits * Women in pregnancy, childbearing potential or breastfeeding * Involvement in other ongoing studies or clinical trial.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Avascular necrosis of humerus are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Krankenhaus Reinbek St. Adolf-Stilt
Reinbek, Germany
-
Orthopädische Klinik Luzern - OKL
Lucerne, Switzerland
-
ULSS 1 Dolomiti - Presidio Ospedaliero Santa Maria del Prato di Feltre
Feltre, 32032, Italy
-
go:h - Gelenkchirurgie Orthopädie: Hannover
Hanover, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Job-Focused rehab program keep arthritis patients employed?
- Can an oral drug calm psoriatic arthritis? phase 3 trial puts deucravacitinib to the test
- Do rheumatic diseases quietly damage the Eye's oil glands?
- Can a questionnaire capture the real burden of psoriatic arthritis?
- Can a new pill calm psoriatic arthritis joint pain?
- A personal nurse and a plan: could this ease the daily burden of arthritis?